Amgen Inc. Q2 beat lifts FY guidance despite LOE headwinds; see portfolio drivers, pipeline catalysts, and M&A limits—click ...

Key Points Interested in Amgen Inc.? Here are five stocks we like better. Amgen reported strong second-quarter results, with ...

As Amgen’s flagship PCSK9 cholesterol drug Repatha enjoys a bit of a renaissance on the back of impressive cardiovascular ...

For Amgen, the pipeline remains especially important. Biotechnology companies depend on continuous development because existing medicines eventually face competition, changing treatment standards, and ...

Antibody discovery firm AbCellera Biologics has hired Neil Aubuchon, formerly global marketing lead for Amgen’s general medicine early portfolio, as its chief commercial officer. A 20-year industry ...

Amgen (NASDAQ: AMGN) today announced the appointment of Anthony (Tony) Hooper, executive vice president, Global Commercial Operations, effective October 26th. In this role, Hooper will report to ...

This is read by an automated voice. Please report any issues or inconsistencies here. Amgen, a Thousand Oaks-based biotechnology giant, has acquired Dark Blue Therapeutics Ltd., a privately held ...

BAD HOMBURG, Germany--(BUSINESS WIRE)--Fresenius Medical Care, the world’s leading renal therapy company, today announced that it has entered into a new agreement with Amgen Europe (Amgen) for Aranesp ...

One of the world’s largest biotechnology companies is planning a major expansion at its headquarters in Southern California, even as some life sciences landlords struggle to fill already-delivered ...

Amgen (NasdaqGS:AMGN) received a positive opinion from the European Medicines Agency’s CHMP for an expanded Repatha ...